alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 9,926–9,950 of 27,380 studies, newest first · page 398 of 1096.

August 2021 25

  1. 2021-08-05

    Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer's continuum

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: The degree of PVS significantly increased with age in both, BG and CS regions independently of cardiovascular risk factors. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2021-08-05

    Novel blood test for early biomarkers of preeclampsia and Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Scientific reports

    Key finding: In conclusion, we have developed a novel, noninvasive diagnostic and predictive assay for AD, MCI and PE.

    Full summary, score breakdown and related studies → Original source

  3. 2021-08-05

    Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition

    ✓ Peer-reviewed Prevention trials Frontiers in nutrition

    Key finding: Many studies have associated the Mediterranean diet with a decreased risk of dementia and AD, but a cause-and-effect relationship has not been deduced. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2021-08-05

    Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study

    ✓ Peer-reviewed Disease mechanisms Acta neuropathologica communications

    Key finding: We found no association between Braak stage and cognitive impairment when controlling for age (p = 0.76). +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2021-08-04

    BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology

    ✓ Peer-reviewed Inflammation and the immune system iScience

    Key finding: BAD pro-apoptotic activity is significantly increased in neurons of AD patients and 5XFAD mice. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2021-08-04

    Fine Particulate Matter and Dementia Incidence in the Adult Changes in Thought Study

    ✓ Peer-reviewed Risk factors Environmental health perspectives

    Key finding: We report 1,136 cases of incident dementia among 4,166 individuals with nonmissing APOE status. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2021-08-03

    Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

    ✓ Peer-reviewed Digital health tools The Lancet. Child & adolescent health

    Key finding: Illness duration and symptom prevalence, duration, and burden were analysed for children testing positive for SARS-CoV-2 for whom illness duration could be determined, and were assessed overall and for younger (age 5-11 years) and older (age 12-17 years) groups. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2021-08-03

    The Humanoid Robot Sil-Bot in a Cognitive Training Program for Community-Dwelling Elderly People with Mild Cognitive Impairment during the COVID-19 Pandemic: A Randomized Controlled Trial

    ✓ Peer-reviewed Prevention trials International journal of environmental research and public health

    Key finding: A 6-week robot-assisted, multi-domain cognitive training program can improve the efficiency of global cognitive function and depression during cognitive tasks in older adults with MCI, which is associated with improvements in memory and executive function. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2021-08-02

    Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?

    ✓ Peer-reviewed Treatments EMBO Molecular Medicine

    Key finding: On 7 June , the FDA approved aducanumab, the first new drug for Alzheimer’s disease in almost 20 years—and notably, the first drug with a putative disease‐modifying mechanism for the treatment of this devastating disorder, namely the removal of β‐amyloid (or Aβ) plaques from the brain.

    Full summary, score breakdown and related studies → Original source

  10. 2021-08-02

    Association Between Dementia Care Programs in Assisted Living Facilities and Transitions to Nursing Homes in Ontario, Canada: A Population-Based Cohort Study

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Medical Directors Association

    Key finding: There were 11.8 transitions to a nursing home per 100 person-years among older adults who resided in an assisted living facility with a dementia care program, compared with 20.5 transitions to a nursing home per 100 person-years among older adults who resided in an assisted living facility without a dementia care program. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2021-08-02

    MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

    ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology

    Key finding: Individuals with AD had high CSF pT217/T217 and low Aβ42/40. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2021-08-02

    Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure

    ✓ Peer-reviewed Digital health tools Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Key finding: Because the blood-brain barrier (BBB) leakage is a well-known risk factor for AD, brain organoids are exposed to human serum to mimic the serum exposure consequence of BBB breakdown in AD patient brains. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2021-08-02

    Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies

    ✓ Peer-reviewed Long-term cohort studies Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plasma proteins affect biological processes and are common drug targets but their role in the development of Alzheimer's disease and related dementias remains unclear. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2021-08-02

    Longitudinal Association of Total Tau Concentrations and Physical Activity With Cognitive Decline in a Population Sample

    ✓ Peer-reviewed Tau biomarkers JAMA network open

    Key finding: New technology is convenient for measuring blood total tau concentrations and provides a unique and increased opportunity for early intervention to slow cognitive decline. +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2021-08 month only

    The Gut-Brain Axis: Literature Overview and Psychiatric Applications

    ✓ Peer-reviewed Disease mechanisms Federal practitioner : for the health care professionals of the VA, DoD, and PHS

    Key finding: Clinicians are encouraged to consider patients' gut health when evaluating and treating psychiatric conditions, such as anxiety and depression. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2021-08 month only

    [Post-stroke cognitive deficits and dementia]

    ✓ Peer-reviewed Risk factors Therapeutische Umschau. Revue therapeutique

    Key finding: An overall model sufficiently predicting post-stroke cognitive outcome was therefore missing until now. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2021-08-01

    Aducanumab: First Approval

    ✓ Peer-reviewed Treatments Drugs

    Key finding: According to the US FDA prescribing information, treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2021-08-01

    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: For autosomal dominant Alzheimer's disease, we found higher functional MRI-assessed system segregation to be associated with an attenuated effect of estimated years from symptom onset on global cognition (P = 0.007). +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2021-08-01

    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Brain : a journal of neurology

    Key finding: Early-onset Alzheimer's disease, defined as manifesting before age 65, is viewed as a relatively pure form of Alzheimer's disease with a more homogeneous neuropathological substrate. +3 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2021-08-01

    Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

    ✓ Peer-reviewed Risk factors The Lancet. Neurology

    Key finding: These findings provide the rationale to develop reliable biomarkers that can better predict conversion to clinically manifest α-synucleinopathies.

    Full summary, score breakdown and related studies → Original source

  21. 2021-08-01

    Dementia Diagnosis Disparities by Race and Ethnicity

    ✓ Peer-reviewed Disparities Medical care

    Key finding: When diagnosed, non-Hispanic Blacks and Hispanics may have more advanced dementia.

    Full summary, score breakdown and related studies → Original source

  22. 2021-08-01

    Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and 18 F-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of Alzheimer disease

    ✓ Peer-reviewed Biomarkers Internal medicine journal

    Key finding: Clinicians reported high diagnostic confidence in 83% of 18 F-FDG PET compared to 67% for CBF-SPECT (P = 0.001). +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2021-08-01

    Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

    ✓ Peer-reviewed Biomarkers The Lancet. Neurology

    Key finding: Due to trisomy of chromosome 21 and the resultant extra copy of the amyloid precursor protein gene, nearly all adults with Down syndrome develop Alzheimer's disease pathology by the age of 40 years and are at high risk for dementia given their increased life expectancy compared with adults with Down syndrome in the past.

    Full summary, score breakdown and related studies → Original source

  24. 2021-08-01

    Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: Previous studies have suggested that the APOE ɛ4 allele plays a role in the risk and age at onset of dementia in DS; however, data on in vivo biomarkers remain scarce. +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2021-08-01

    Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: Among 1431 participants, the mean (SD) age was 71.2 (8.8) years; 751 (52.5%) were male. +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →